Compare Aspen Aerogels Inc (ASPN) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Aspen Aerogels IncTrade

Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Aspen Aerogels Inc vs Citius Pharmaceuticals Inc — how do they compare? Aspen Aerogels Inc trades at $6.15 (market cap $509.55M), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Aspen Aerogels Inc is far larger — about 25.5× Citius Pharmaceuticals Inc's market cap, and Aspen Aerogels Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

	ASPN	CTXR
Market Cap	$509.55M	$20.01M
Sector	Technology	Health
52-Week High	$8.82	$1.82
52-Week Low	$2.57	$0.48
Enterprise Value	$482.96M	$16.23M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASPN

Aspen Aerogels posts stronger Q2 revenue and EBITDA, signals further recovery in Q3 despite challenges.Seeking Alpha · 2 days agoNeutral Aspen Aerogels poised for growth with EV battery barriers and new material uses in data centers and grids.Seeking Alpha · 2 days agoBullish View details →

CTXR

Citius Oncology appoints Jonathan Peri as new independent board member to strengthen governance.PRNewsWire · 4 hours agoBullish View details →

About Aspen Aerogels Inc

Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.